NEW YORK (GenomeWeb News) – Sequenom said today that the underwriters of its recently completed public offering of common stock have exercised an option to acquire an additional 825,000 shares.
 
Last week, the firm offered 5.5 million shares of common stock at $15.50 per share.
 
The exercise of the over-allotment option brings the total number of shares sold to 6,325,000 and net proceeds to $92 million.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.